Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data

Table 6 Hepatitis C virus seropositivity among patients other than those with liver disease

S. #	Year	Place	Method	Sample size	Seroprevalence (%)	Ref.
Urological patients
1	2010	Lahore	ELISA4	558	13.4	[130]
Major gynecological surgery
2	2009	Karachi	EIA1	548	16.2	[106]
Surgery (eye/elective/major)
3	2010	Sukkur	ICT5	913	13.8	[126]
4	2011	KPK	ICT2	25	8.0	[111]
5	2013	Kharian	ELISA5	554	6.4	[122]
Dental surgery
6	2011	KPK	ICT2	35	14.28	[111]
Type II diabetes
7	2010	Multan	ELISA3	3000	30.2	[88]
Cataract patients
8	2012	Karachi	ELISA5	377	11.4	[127]
Dermatological disorders
9	2012	Karachi/Rawalpindi	ELISA5	355	9.01	[128]
Tuberculosis patients
10	2013	Rahim Yar Khan	ELISA4	110	9.1	[121]
Sexually transmitted infection patients
11	2014	Faisalabad	ELISA1	39780	21.99	[124]
Seeking hospital care (Misc diseases/disease not defined)
12	2010	Bannu	ELISA5	25944	3.3	[125]
13	2011	Karachi	ELISA1	2965	12.8	[123]
14	2011	Kotli (AJK)	ELISA5	9564	6.38	[129]

¹Abbott Diagnostics;

²Acon Laboratories;

³Labkit;

⁴Bio-tech Company Limited, United States;

⁵Manufacturer not mentioned in cited reference. KPK: Khyber Pakhtunkhwa; ELISA: Enzyme linked immunosorbent assay; EIA: Enzyme immunoassay; ICT: Immunochromatographic test.